Extracted pages from Report-of-the-Exper-Group--Future-Pandemic-preparedness-and-emergency-response_0_Part3
Extracted pages from Report-of-the-Exper-Group--Future-Pandemic-preparedness-and-emergency-response_0_Part3
Concern (PHEICs) have been declared by the World Health Organisation (WHO).
These include the H1N1 influenza (2009), Ebola Virus Disease (EVD) (2014-16, 2018-
2020), Zika Virus Disease (ZVD) (2016), Poliomyelitis (2014), COVID-19 (2020),
and Monkey Pox (2022). In addition, the world has tackled public health threats of
SARS, Avian influenza (bird flu), MERS-CoV, and Nipah virus outbreak which have
challenged health systems across countries. However, it is worth mentioning that
the COVID-19 pandemic was more complex in terms of high public health impact,
recurring waves and unpredictable course due to changing pathogenicity associated
with virus mutations and variants. This has highlighted the importance of a targeted
approach towards zoonotic and other potential pathogens that are likely to emerge
in the future. Such threats could be due to emerging and re-emerging pathogens,
or could also arise due to newly emerging pathogens from viruses which routinely
are infective for bats or other avian populations but may cross over to humans due
to frequent mutations directly or via vectors due to environmental or occupational
aspects of human animal interface. Considering the above aspects, the Government
of India is in the process of launching the One Health (OH) Mission, focusing on
multi-disciplinary human, animal and environmental sectors through an effective
integrated surveillance ecosystem, joint outbreak response system and targeted
research.
While the One Health (OH) approach is crucial for addressing many pandemic threats,
there are challenges from CBRN agents, threats from bioterrorism, the possibilities of
deliberate release of pathogens for malicious purposes and pandemic scenarios that
extend beyond its scope and require strategies which are beyond the OH approach
involving national security, international collaborations with inter-disciplinary
approach and high-tech systems. Further, factors like increased travel and trade
due to globalisation, effects of climate change on pathogens, and determinants of
pathogenicity among vulnerable groups, including emerging resistant pathogens
and social determinants of health, require a separate mechanism.
Globally, countries and multi-lateral organisations are working towards preparedness
to deal with novel pathogens and disease outbreaks. WHO has already identified
around 30 viral and bacterial families, which could have potential for epidemics or
pandemics and hence need to be targeted for future research, development of new
laboratory techniques for diagnosis, and countermeasures. The WHO has revised
the International Health Regulations (IHR) to reflect the post pandemic reality; Inter-
governmental negotiations on a Pandemic Accord were also conducted and a global
scientific framework for epidemic and pandemic research preparedness is being
developed. The recent 77th World Health Assembly also highlighted the need for a
collaborative surveillance framework and developing a roadmap for epidemiological
capacity building at all levels and aligning with regional and global initiatives.
Therefore, it is imperative that countries also take stock of their needs and prepare
a robust road map aligned with global instruments like Preparedness and Resilience
for Emerging Threats (PRET) and obligations under International Health Regulations
(IHR), which are legally binding on all WHO member countries for preparing and
responding to future pandemic threats to public health systems.
2.2 Research
Research complementing future pandemic priorities has also been undertaken by
the Expert Group. This includes research on the work being undertaken by global
health organisations, multi-lateral groups like the Independent Panel for Pandemic
Preparedness and Response Secretariat (IPPRS), the 100 days Mission, etc.
Published literature on the COVID-19 pandemic, evolving science about the SARS-
CoV2 pathogen, COVID-19 disease and its sequelae have also been considered
by the Expert Group in its deliberations. Details of key references are included at
Annexure IV.
4.1 Governance
i. The whole–of-government, whole-of-society approach, and inter-
departmental, inter-ministerial, and centre-state coordination worked well
during COVID -19.
ii. Role of Empowered Group Systems, National Task Forces – NTAGI & NEG-
VAC were critical for quick decision-making and interagency coordination
iii. Science-based evidence played a key role in informed decision-making.
This evolved with a scientific understanding of the pathogen and disease,
iv. The role and responsibility of each agency and organisation however,
required more clarity, and the mechanisms for close coordination of
agencies to work together were not in place.
v. Risk communication systems need to be established. What was missing
in COVID management was a well-developed communication mechanism
which allowed data to flow both ways.
vi. The need was also felt for a well-defined rapid response SOP/instruction
document and delegation of powers to empower key officials to act without
going through the multilayered hierarchal process. This was essential for
speedy time-bound action.
4.2 Legislation
i. The National Disaster Management Act (NDMA) was enforced – enabling
Centre and State government to respond quickly and implement public
health measures.
ii. However, a need is felt for a specific Public Health Act.
iii. Provisions of NDMA are not entirely suited for a public health emergency
and its public health and clinical management.
iv. The previous epidemic act has a limited scope and is not suited to the
modern approach for pandemic/epidemic management.